Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,17605,602,2.22 [1.83-2.70],1.405861102860151e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20481,735,1.41 [1.30-1.52],3.9292525727356375e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,20742,747,0.35 [0.28-0.45],9.481765210644216e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,18244,629,3.34 [2.53-4.42],2.840571950310339e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,20544,736,2.12 [1.92-2.33],1.3094333202371288e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACHE,Acetylcholinesterase,17844,612,1.67 [1.34-2.09],4.435197846985472e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,17696,610,0.67 [0.55-0.81],5.882132567206749e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,21057,757,2.48 [2.03-3.02],2.1740348686886613e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,17696,610,1.35 [1.28-1.43],1.7147978441965028e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTA2,"Actin, aortic smooth muscle",20544,736,1.78 [1.58-2.01],2.768228416414272e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,20714,742,3.90 [3.15-4.82],3.539864077869097e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,20948,755,1.96 [1.78-2.16],2.8405005440741803e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17605,602,1.73 [1.52-1.98],2.501055862702144e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,20853,742,3.41 [2.97-3.92],1.038416555841637e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17696,610,3.13 [2.58-3.80],1.0589238092735404e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,20544,736,1.86 [1.50-2.32],2.6359956812929586e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20749,742,1.79 [1.50-2.15],2.355979419335815e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21152,759,2.00 [1.62-2.47],7.538531927560162e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21071,757,1.65 [1.32-2.05],7.877522558720329e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18143,620,5.77 [4.62-7.21],1.7431500077962506e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17696,610,1.65 [1.32-2.07],1.3258760636168496e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17696,610,1.60 [1.29-1.98],1.995775668498037e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,21030,757,0.70 [0.60-0.81],3.231276627325809e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,18244,625,6.74 [5.58-8.13],2.738156799998929e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,20714,742,2.53 [2.08-3.08],2.142823270909392e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,17844,612,2.66 [2.21-3.21],4.639041899370102e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,18143,620,1.32 [1.16-1.52],4.483078769541874e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,21031,754,3.19 [2.54-3.99],5.206555940113575e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,21117,758,3.22 [2.67-3.88],7.98586187720811e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,20846,753,2.15 [2.03-2.28],4.11490048704301e-153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,20948,755,0.12 [0.10-0.15],2.347872478715472e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,20544,736,1.31 [1.20-1.42],9.405025513333019e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,18266,624,0.55 [0.50-0.61],1.8988409501899727e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,21118,762,4.82 [3.72-6.24],1.2293348494772863e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,20678,741,0.50 [0.45-0.56],6.792129889971373e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,20299,723,1.60 [1.50-1.70],2.577290198371821e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,20439,735,1.67 [1.51-1.85],4.800576621798075e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,21031,754,3.66 [3.14-4.26],2.835719319509799e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,21152,759,1.65 [1.45-1.87],1.3369455562964422e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,20948,755,1.61 [1.49-1.74],1.3294430953039064e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20815,753,1.22 [1.15-1.30],3.8346597058317185e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,17732,612,1.75 [1.59-1.93],5.5231717299851926e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,17696,610,1.46 [1.31-1.61],4.726676880559823e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,21203,763,2.21 [1.63-2.98],2.7243844849704524e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,20961,753,1.30 [1.16-1.46],3.945883842665083e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",20850,748,1.47 [1.36-1.58],2.9796359804781758e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,17696,610,1.18 [1.10-1.25],1.1742483722929904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,20921,745,2.35 [1.97-2.81],2.754900661994204e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,21118,762,2.75 [2.35-3.21],2.1625520474105363e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,20961,751,1.39 [1.18-1.64],9.905907060543806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,20982,748,0.27 [0.23-0.32],6.702858710974972e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,20992,751,2.76 [2.37-3.20],8.686071397392657e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,21118,762,2.83 [2.38-3.36],3.804403914467125e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,20471,728,1.39 [1.30-1.50],2.51060872990038e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,20406,727,1.99 [1.61-2.45],1.8445460435783848e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,21065,749,7.53 [6.02-9.41],2.0779688165561728e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APCS,Serum amyloid P-component,18091,619,0.45 [0.36-0.56],1.142682324786849e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,20948,755,0.64 [0.56-0.74],1.4830555295954775e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,18266,624,0.11 [0.08-0.15],4.494116537804861e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA2,Apolipoprotein A-II,18244,629,1.39 [1.20-1.62],2.1045743314771875e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,18266,624,3.34 [2.84-3.94],1.8463062955959919e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOBR,Apolipoprotein B receptor,17770,611,0.68 [0.56-0.81],3.1588972262818435e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,18236,624,0.13 [0.10-0.16],2.1191432437550782e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,17490,595,0.21 [0.16-0.27],2.537626565699117e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,18266,624,0.49 [0.42-0.58],1.647157602391305e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,18244,629,0.30 [0.24-0.38],7.36686338085531e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,20961,753,1.68 [1.41-1.99],3.203133257222561e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,18244,629,0.44 [0.37-0.51],1.719379497063509e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,21020,749,0.10 [0.08-0.13],5.037554260800469e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,20846,753,4.36 [3.85-4.94],3.58533871740228e-118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,17634,602,1.25 [1.13-1.39],1.4600474484258652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,21065,749,2.10 [1.78-2.48],2.149885487783147e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,18051,623,1.52 [1.32-1.76],9.394642924152376e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,20749,742,5.76 [4.70-7.06],4.0191729411315944e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR2,Asialoglycoprotein receptor 2,18244,629,2.77 [2.12-3.63],8.954618322296779e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,17605,602,1.31 [1.18-1.45],2.7645832665877214e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATP6AP2,Renin receptor,20481,735,1.37 [1.18-1.59],3.736679917555515e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,18143,620,3.02 [2.48-3.67],5.060796222119787e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",18266,624,2.62 [1.63-4.22],7.210886635860598e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,21065,749,1.96 [1.54-2.48],3.0435667374582724e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,18266,624,2.61 [2.19-3.12],2.3292442676422948e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17770,611,5.23 [4.16-6.58],3.176649533357668e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",21031,754,3.76 [3.02-4.68],1.3447590449486502e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAG3,BAG family molecular chaperone regulator 3,20714,742,0.68 [0.58-0.79],8.600134132891512e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20481,735,1.84 [1.68-2.02],1.7656736358752115e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,20481,735,2.42 [1.98-2.95],3.2652504143811825e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,20961,753,2.27 [1.76-2.91],1.4309971412049442e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,20749,742,0.24 [0.20-0.29],3.1882365683416293e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20891,749,1.95 [1.62-2.34],1.1550661699479365e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L15,Bcl-2-like protein 15,17696,610,1.34 [1.19-1.51],2.435130220540432e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,18244,625,0.70 [0.64-0.76],3.441947491854104e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLMH,Bleomycin hydrolase,21203,763,0.64 [0.52-0.79],2.7320287385091032e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP4,Bone morphogenetic protein 4,20714,742,1.43 [1.25-1.64],2.668192729683879e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,17844,612,6.78 [4.96-9.27],4.6744252689127566e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17696,610,1.65 [1.40-1.95],3.846139659928772e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,20544,736,4.64 [3.49-6.17],4.178235324511671e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB1,BPI fold-containing family B member 1,20890,749,0.70 [0.64-0.78],5.211223202627412e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSG,Basigin,21121,757,3.08 [2.29-4.14],1.0637972648317729e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,21111,758,1.45 [1.30-1.61],3.332519413663666e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,21031,754,4.70 [3.83-5.77],7.601835330454884e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,20891,749,1.85 [1.59-2.16],3.9266574233999316e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,20471,728,1.34 [1.23-1.46],2.7936585414258987e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QA,Complement C1q subcomponent subunit A,21055,756,2.72 [2.03-3.65],2.350098099520929e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QL2,Complement C1q-like protein 2,17696,610,0.59 [0.49-0.71],5.15891396004095e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21065,749,2.30 [2.00-2.65],8.59368069424295e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,21020,749,2.76 [1.97-3.87],3.2224132228407687e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C4BPB,C4b-binding protein beta chain,21030,757,0.58 [0.49-0.68],2.602497994212048e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,17813,611,8.13 [6.40-10.32],2.189345048035812e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C8B,Complement component C8 beta chain,18266,624,0.51 [0.40-0.66],2.206805233411724e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,18244,629,0.75 [0.65-0.86],3.653465857328297e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,20846,753,4.25 [3.56-5.07],9.53917708897388e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA3,Carbonic anhydrase 3,21169,762,1.25 [1.13-1.39],2.9573370509631666e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",20544,736,1.36 [1.27-1.45],4.483396483766728e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,20903,750,0.79 [0.72-0.88],1.0988861900520776e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,21118,762,2.25 [2.01-2.53],6.673122694740585e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB1,Calbindin,20846,753,1.70 [1.47-1.97],1.6567701653897837e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,20471,728,1.54 [1.30-1.82],3.754692701229136e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,20715,740,1.64 [1.52-1.77],3.818544841496012e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCB,Calcitonin gene-related peptide 2,18201,625,1.68 [1.45-1.95],4.576054967505722e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CANT1,Soluble calcium-activated nucleotidase 1,20873,752,2.13 [1.54-2.94],4.450632261653068e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,20765,752,1.40 [1.25-1.56],3.7168502593903923e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,20907,755,1.76 [1.61-1.91],1.5247942935464293e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,17770,611,1.48 [1.29-1.69],1.5669921015405328e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCDC80,Coiled-coil domain-containing protein 80,20948,755,1.51 [1.28-1.79],9.478622690164916e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,21152,759,3.78 [3.14-4.55],2.6649869189345752e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL14,C-C motif chemokine 14,20921,745,1.46 [1.25-1.70],1.4066875041667622e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,21203,763,3.37 [2.97-3.84],5.3907387458756327e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,21203,763,1.85 [1.62-2.11],1.011827731912903e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,21152,759,1.38 [1.30-1.47],6.0080395024110944e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,21031,754,1.82 [1.61-2.05],4.453553531292369e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,21152,759,2.24 [1.95-2.58],3.140926080730689e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL28,C-C motif chemokine 28,20817,747,1.27 [1.14-1.42],1.883831429004391e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,20891,749,1.28 [1.18-1.39],5.717695164105874e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,20891,749,1.26 [1.14-1.40],8.357344837371541e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,21171,763,1.92 [1.63-2.27],2.116356018065567e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,21118,762,2.40 [2.07-2.79],9.255495342839652e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,20961,753,2.65 [2.27-3.10],7.82593233572896e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCS,Copper chaperone for superoxide dismutase,20749,742,0.66 [0.57-0.77],6.888218186290927e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,18143,620,1.77 [1.47-2.13],1.2046384474324467e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,20961,753,2.40 [1.96-2.95],4.872240399332418e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,20562,735,1.60 [1.37-1.88],7.0810961921261926e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,21152,759,2.17 [1.92-2.46],2.4640546405464604e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,21065,749,2.26 [1.95-2.61],4.198513800351088e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,20961,753,1.98 [1.65-2.39],6.589393532895233e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,21030,757,0.37 [0.28-0.47],3.108404914741571e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD2,T-cell surface antigen CD2,17605,602,1.44 [1.23-1.68],5.9908311449858665e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,20473,738,2.78 [2.35-3.28],2.3474361132187945e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD209,CD209 antigen,21008,757,0.66 [0.56-0.79],4.351245506126408e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,21152,759,1.73 [1.36-2.19],6.479366493538565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,18244,625,0.47 [0.39-0.57],6.6152624579142e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,21030,757,3.83 [3.36-4.37],1.5098191820594345e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,20749,742,2.37 [2.01-2.79],6.9117623839766005e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,20935,749,5.05 [4.19-6.09],4.362428583454131e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,20481,735,1.90 [1.64-2.21],6.161760653175538e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,17844,612,2.66 [2.09-3.39],1.893887583453303e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,21111,758,2.47 [2.08-2.93],2.9493525471390028e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,21047,758,2.01 [1.75-2.32],1.452523527137474e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LF,CMRF35-like molecule 1,21118,762,1.48 [1.32-1.66],1.2177036353052442e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,20846,753,4.07 [3.42-4.85],5.096739755130545e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,21049,754,0.33 [0.25-0.43],4.040742491783051e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,17696,610,1.42 [1.20-1.69],5.835342508725162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20846,753,3.27 [2.78-3.85],4.0292469036065396e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,20858,748,2.01 [1.69-2.39],4.8511844231063016e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,20931,748,1.48 [1.30-1.68],2.085996845516295e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,20857,744,2.52 [2.05-3.10],9.801648966770221e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,20992,751,2.83 [2.30-3.47],1.7477034757192568e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,21082,762,2.18 [1.85-2.57],6.361344476267974e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD55,Complement decay-accelerating factor,20250,727,1.77 [1.41-2.23],1.2025472395975166e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,20234,719,4.13 [3.34-5.11],8.041407440934375e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,20714,742,1.36 [1.18-1.56],1.3116072718957191e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,17655,608,1.87 [1.59-2.20],1.8427196047465824e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,17844,612,1.71 [1.45-2.01],1.6615575434934827e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,21111,758,3.40 [2.88-4.02],2.2865536474306865e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,21152,759,2.32 [2.07-2.61],1.3482519478950184e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,18235,622,2.99 [2.47-3.61],1.1102663097799657e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,20891,749,2.06 [1.73-2.45],1.976210714300388e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,21111,758,1.75 [1.55-1.97],1.679423065906634e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99,CD99 antigen,20961,753,4.81 [3.64-6.35],1.7167511358863694e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,20749,742,1.83 [1.63-2.04],2.9790971036848637e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,20292,726,3.62 [3.20-4.11],2.5640448023523046e-90
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,21077,756,1.81 [1.68-1.95],3.598786903912415e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,20948,755,2.07 [1.90-2.26],1.8592488812002423e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,20948,755,2.80 [2.33-3.37],1.2973224859164948e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH3,Cadherin-3,21111,758,1.95 [1.66-2.30],3.942590388742024e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,20948,755,1.96 [1.67-2.31],5.172769415306475e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,20846,753,1.30 [1.19-1.42],1.6571566954544144e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDNF,Cerebral dopamine neurotrophic factor,20846,753,2.18 [1.83-2.61],1.0333721830818401e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,18143,620,1.79 [1.50-2.14],1.9541237920957359e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,17900,617,1.46 [1.26-1.69],6.270365108239912e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,20891,749,1.23 [1.14-1.32],7.513768873089859e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20235,730,1.29 [1.18-1.42],8.5394636776269e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,20544,736,1.56 [1.38-1.77],4.022658309610329e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17844,612,1.76 [1.36-2.26],1.2910209274349398e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,17696,610,1.47 [1.24-1.75],8.735187146515638e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,20846,753,1.75 [1.57-1.95],3.586974616833099e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,20481,735,2.08 [1.85-2.33],4.8126710123417434e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFD,Complement factor D,18266,624,2.70 [1.97-3.71],7.466958798797965e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR2,Complement factor H-related protein 2,18131,619,1.40 [1.20-1.63],2.205265101375293e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,18232,623,0.79 [0.71-0.88],1.189929449137719e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,17999,619,0.67 [0.56-0.79],3.849959600332465e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFP,Properdin,18266,624,0.19 [0.13-0.27],1.1872505241137069e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,20948,755,2.78 [2.40-3.22],4.711016170893006e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,17844,612,0.30 [0.26-0.35],6.289066197734723e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18201,625,3.42 [2.95-3.96],2.7839911869083006e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,18152,622,2.54 [2.08-3.09],4.2759489879445235e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,18244,625,1.66 [1.57-1.77],1.912620503554619e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGB,Secretogranin-1,21048,756,1.95 [1.69-2.25],9.323229556171404e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,20539,736,1.58 [1.47-1.69],5.4152904950189885e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL1,Chordin-like protein 1,20992,751,1.79 [1.47-2.18],5.4429138041523434e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,18244,625,3.39 [2.89-3.98],1.1377809177993356e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,21060,754,4.24 [3.53-5.10],1.118513951563257e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",20877,747,1.37 [1.23-1.52],5.6140549727728844e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC14A,C-type lectin domain family 14 member A,20961,753,2.97 [2.47-3.56],1.930409185928324e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1A,C-type lectin domain family 1 member A,20544,736,2.02 [1.68-2.43],4.8501189047942796e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,20891,749,0.41 [0.35-0.49],4.1924332604555234e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,20891,749,1.72 [1.55-1.91],2.16615952394925e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,18210,624,0.53 [0.44-0.62],1.0183318214707869e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,20888,752,1.55 [1.25-1.91],4.304228641756536e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,20481,735,1.71 [1.50-1.96],5.0866151445781865e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,21152,759,1.78 [1.55-2.05],3.790734563586699e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLGN,Calmegin,17732,612,1.43 [1.23-1.68],5.912380978523158e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLMP,CXADR-like membrane protein,21118,762,2.80 [2.13-3.67],1.4817058108580666e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,21152,759,2.31 [2.02-2.65],2.452533794452144e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,20915,754,0.46 [0.39-0.53],4.539135969629006e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,21118,762,1.52 [1.32-1.75],1.2694123896327772e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,20961,753,3.59 [2.87-4.48],2.0044241976645493e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,20961,753,2.06 [1.56-2.73],3.223458412548791e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,20981,752,0.39 [0.33-0.47],1.5807139097970148e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,20891,749,1.38 [1.18-1.60],4.966463783964203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,21058,754,7.45 [5.76-9.64],1.3858704528090414e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,21203,763,0.43 [0.32-0.56],1.1912581942785668e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,18244,625,3.77 [2.73-5.21],6.665521683071335e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,20948,755,2.76 [2.38-3.21],3.3253264669141998e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,17844,612,2.27 [1.91-2.69],1.4653578198619774e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,21203,763,3.63 [3.14-4.19],2.135055772821631e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL9A1,Collagen alpha-1(IX) chain,20891,749,0.71 [0.62-0.82],3.860438947759592e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,20935,749,4.14 [3.35-5.12],2.6952192998585863e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,20752,739,0.54 [0.44-0.66],2.652837467435917e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17770,611,0.58 [0.46-0.73],2.535912933584984e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20846,753,1.21 [1.10-1.33],7.927090101255908e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,21048,756,2.34 [2.13-2.57],8.306657662990685e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,20999,755,5.08 [4.22-6.11],1.9150306648206688e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,18205,625,1.92 [1.53-2.39],1.219509552389378e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,18235,622,3.62 [2.80-4.68],8.549561990712405e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,21065,749,1.77 [1.54-2.03],1.302035685846144e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREG1,Protein CREG1,20693,746,0.54 [0.45-0.65],1.3103405542456098e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,17844,612,3.38 [2.75-4.15],6.382501751009944e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,20445,734,0.69 [0.63-0.75],6.169462923367154e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,20935,749,5.91 [4.63-7.54],2.652841861108765e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,21031,754,3.13 [2.32-4.22],9.252081665503069e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,20749,742,2.07 [1.78-2.40],3.3380397872354152e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,18086,626,0.36 [0.27-0.47],2.0878966235945053e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,20375,738,0.70 [0.64-0.77],3.1572611135183813e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,21203,763,0.38 [0.31-0.47],3.934884334132136e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRYBB2,Beta-crystallin B2,18201,625,1.19 [1.10-1.28],4.428950543622356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,21031,754,3.73 [3.00-4.65],3.6602469924132405e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,18244,629,2.18 [1.83-2.59],2.2716533669351632e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20749,742,1.26 [1.13-1.40],3.530426364249953e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,21033,746,3.83 [3.16-4.63],3.2383581345482883e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,20970,751,1.19 [1.12-1.27],1.218450863265058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,20670,749,1.78 [1.53-2.06],4.8708559787150266e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,17961,620,3.63 [2.67-4.93],1.734009363489179e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,18244,625,3.42 [2.72-4.30],4.9015351713729485e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,20930,749,0.72 [0.66-0.80],3.606759857897015e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,19638,712,2.44 [2.15-2.78],7.692668198157108e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,17844,612,2.78 [2.38-3.24],3.8606521520463644e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSH,Pro-cathepsin H,20464,735,1.22 [1.11-1.34],2.478112345443069e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,20948,755,3.26 [2.53-4.20],5.0729974008210724e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,21152,759,5.27 [4.33-6.41],9.201875939967807e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,16354,583,4.32 [3.09-6.05],1.345544663354208e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSV,Cathepsin L2,21050,760,0.72 [0.61-0.84],5.735042577071301e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,21012,748,4.15 [3.39-5.08],3.975619692045877e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,17732,612,1.54 [1.31-1.82],2.5967062723067825e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,20891,749,1.56 [1.38-1.76],5.94737221848124e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,20563,744,0.56 [0.47-0.66],6.587249302819649e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,21175,762,2.72 [2.09-3.54],7.877413261036108e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL6,C-X-C motif chemokine 6,21152,759,1.19 [1.09-1.29],9.009788250468808e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,20802,751,1.40 [1.29-1.51],1.3973382145679383e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,21031,754,1.68 [1.45-1.94],2.7997584872410053e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21030,757,4.46 [3.71-5.36],1.1118014508245098e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCN,Decorin,20544,736,3.60 [2.78-4.65],1.4209068558725041e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,21030,757,1.29 [1.15-1.46],2.3980064876390936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20846,753,1.74 [1.52-2.00],1.898542471395263e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,21111,758,2.86 [2.22-3.69],5.750562565436461e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFA1_DEFA1B,Neutrophil defensin 1,20545,727,1.36 [1.22-1.52],4.684910361924105e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,17550,608,1.45 [1.25-1.68],6.374897145368525e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB4A_DEFB4B,Beta-defensin 4A,20662,748,1.09 [1.05-1.14],7.100271885654979e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,17844,612,0.45 [0.34-0.60],2.8612545309462485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,20720,742,2.64 [2.34-2.98],3.7020916580504043e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,21030,757,5.52 [4.57-6.67],1.0926940145600762e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,17770,611,1.48 [1.30-1.68],3.381750507179782e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,17770,611,0.41 [0.37-0.45],1.4774405610730852e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,20889,748,0.41 [0.31-0.54],9.357383289487468e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNM3,Dynamin-3,18196,621,1.35 [1.18-1.53],6.078023529368061e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNMBP,Dynamin-binding protein,20749,742,1.27 [1.14-1.42],1.1759227521410358e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP4,Dipeptidyl peptidase 4,20598,737,0.46 [0.36-0.58],8.866301225774187e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,20846,753,2.86 [2.36-3.46],1.0647678541748326e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP7,Dipeptidyl peptidase 2,20790,752,1.29 [1.16-1.44],5.934480305498136e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,21203,763,2.44 [1.85-3.23],3.874468435853411e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,21038,757,1.52 [1.38-1.67],4.317871894133622e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,20747,746,4.82 [4.06-5.73],5.276326427336287e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,18196,621,1.96 [1.57-2.44],1.6986243695697154e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,20961,753,1.79 [1.42-2.26],1.1301390232026342e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,20785,752,0.58 [0.51-0.66],1.6900492606585784e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,18113,621,2.69 [2.32-3.13],9.597835985278646e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,20846,753,2.06 [1.63-2.61],2.257517956128178e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",18143,620,1.26 [1.17-1.36],3.488293395208101e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,21082,760,2.05 [1.66-2.53],1.956730727122796e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18235,622,1.39 [1.26-1.53],1.887991786160469e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",17770,611,1.28 [1.18-1.39],6.3151442065274e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,21118,762,3.54 [3.09-4.06],4.319814568188712e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDDM3B,Epididymal secretory protein E3-beta,18152,622,1.32 [1.20-1.44],8.942406954673402e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,20544,736,1.67 [1.39-2.01],6.17264829192807e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,17770,611,2.97 [2.32-3.81],7.451774604919049e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,18143,620,2.85 [2.31-3.51],4.79477466728569e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21037,748,2.79 [2.30-3.38],1.7585892782888432e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,20928,751,4.48 [3.71-5.40],4.2213061314116836e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,20714,742,5.62 [4.78-6.60],3.6154729116686703e-97
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,20481,735,1.78 [1.52-2.07],3.559200234107125e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,21203,763,0.15 [0.10-0.22],1.2140005324500058e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,20891,749,1.24 [1.12-1.37],3.3376336739325965e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENDOU,Poly(U)-specific endoribonuclease,16806,575,1.43 [1.26-1.62],4.044607059936916e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20253,721,1.22 [1.13-1.32],1.4898593161594638e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,20544,736,0.24 [0.18-0.32],6.1027915028315335e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,20544,736,2.93 [2.20-3.89],1.4095039933164508e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,20926,750,0.73 [0.68-0.79],7.884215772829586e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,21005,754,2.91 [2.38-3.56],3.293424420655833e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,20196,733,5.18 [4.36-6.15],1.5732449844968564e-78
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,17844,612,2.28 [1.74-2.98],2.0463773248279742e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,21203,763,4.44 [3.58-5.50],3.717606597536531e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB6,Ephrin type-B receptor 6,20715,740,1.92 [1.58-2.33],3.4017097188102494e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,20891,749,1.60 [1.49-1.71],6.84934807627735e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21074,759,3.41 [2.82-4.14],6.36634429962535e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,17696,610,2.31 [1.95-2.73],3.546197329107306e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,21203,763,3.04 [2.52-3.67],2.7295003860776744e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESYT2,Extended synaptotagmin-2,18201,625,1.27 [1.15-1.40],9.864729550981316e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,18244,629,0.50 [0.39-0.65],1.485515396579021e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,20961,753,1.50 [1.34-1.69],7.400271355492427e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,18166,624,0.25 [0.19-0.34],4.8399207775043575e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2,Prothrombin,18266,624,0.28 [0.16-0.46],1.1776967903142475e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,20992,751,1.50 [1.33-1.69],6.126222372211089e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",20935,749,1.96 [1.84-2.09],1.1436638543297368e-93
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",20948,755,1.38 [1.28-1.50],1.207831301275957e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",18235,622,2.27 [2.01-2.56],2.6129571056634638e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",21203,763,1.85 [1.67-2.05],9.098221759351073e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,21029,754,1.35 [1.23-1.49],6.153099826563847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP6,Gastrotropin,20506,736,1.29 [1.16-1.44],2.897507553839284e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,18235,622,1.75 [1.33-2.29],5.099832071562651e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,20846,753,6.17 [4.99-7.62],3.032771760588228e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,20907,755,8.23 [6.78-10.00],4.969754995688684e-100
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,18143,620,2.24 [2.04-2.47],2.1896537202228604e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,21142,760,1.90 [1.66-2.18],7.482960819544753e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,21152,759,0.47 [0.40-0.56],2.6423962866257377e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBLN2,Fibulin-2,18244,625,2.55 [2.06-3.16],8.543683561532856e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,18235,622,1.67 [1.51-1.85],1.4983158339915411e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,20891,749,1.46 [1.27-1.68],5.897441406426005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,20961,753,1.36 [1.21-1.52],8.435692741793703e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN2,Ficolin-2,20889,745,0.55 [0.48-0.64],3.1360759565772966e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL2,Fc receptor-like protein 2,21041,758,1.35 [1.20-1.52],3.4637206343531614e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL5,Fc receptor-like protein 5,20961,753,1.47 [1.33-1.64],2.456383467279308e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,20481,735,1.41 [1.30-1.52],8.225300553361221e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",17605,602,1.29 [1.16-1.45],5.716094585514515e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,21031,754,0.73 [0.67-0.80],2.790236844845005e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,21082,760,1.37 [1.30-1.44],5.358293605450987e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,21089,759,1.73 [1.59-1.89],8.327621563355401e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,20563,744,2.31 [1.92-2.78],1.2325718976644136e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,21030,757,0.14 [0.11-0.17],9.611948197023242e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,18244,625,0.37 [0.31-0.43],3.947106420708626e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,18201,625,0.34 [0.27-0.42],2.289203355933958e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,21030,757,9.97 [7.65-13.00],5.7851128598540025e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR4,Fibroblast growth factor receptor 4,17844,612,0.70 [0.60-0.81],4.814530673305166e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,18244,629,1.44 [1.28-1.62],9.48625335915683e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20749,742,2.43 [1.94-3.06],2.1649706656528564e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,21152,759,1.76 [1.45-2.13],9.194326307643323e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FN1,Fibronectin,18266,624,0.54 [0.40-0.73],7.043147903234091e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,20942,754,2.15 [1.76-2.62],5.386063563953569e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR2,Folate receptor beta,21111,758,1.75 [1.41-2.17],4.70274476407898e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSHB,Follitropin subunit beta,17770,611,0.81 [0.74-0.88],5.36979179458751e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,20992,751,0.54 [0.47-0.63],3.347183409013204e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,17770,611,4.74 [3.39-6.63],9.146931771681234e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,20894,748,3.19 [2.69-3.77],4.222838849930569e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,18162,624,1.35 [1.24-1.48],3.527578941639267e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,17844,612,1.46 [1.29-1.64],5.350102258042466e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21111,758,1.82 [1.58-2.08],1.7245700026487386e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20846,753,3.99 [3.15-5.07],3.165764453781304e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,20563,744,1.86 [1.60-2.16],6.871827059744864e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,20846,753,5.89 [4.25-8.17],1.9954399911078086e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,18201,625,1.32 [1.26-1.38],1.535137281808071e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GC,Vitamin D-binding protein,18266,624,0.52 [0.37-0.71],5.757454949310178e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,20481,735,1.70 [1.60-1.79],1.0121090121234611e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17415,597,1.42 [1.23-1.63],1.8925022613024009e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20846,753,2.48 [2.06-2.98],4.086203426277696e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,21203,763,8.72 [7.71-9.87],2.907676087017411e-257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,20471,728,2.07 [1.78-2.42],1.9875690448936104e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFAP,Glial fibrillary acidic protein,20446,735,0.74 [0.65-0.86],4.741310602579761e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,21082,760,5.61 [4.61-6.84],4.111032943878988e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA3,GDNF family receptor alpha-3,20693,741,1.78 [1.42-2.23],4.937013795252776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRAL,GDNF family receptor alpha-like,17647,605,0.67 [0.58-0.77],1.0580857604876431e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,20928,751,1.64 [1.46-1.84],1.7978912666170302e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,20749,742,8.40 [6.50-10.86],3.623611042589233e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,17844,612,0.47 [0.35-0.63],3.404615278150764e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,20948,755,0.82 [0.76-0.89],5.343757201401532e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,17844,612,0.34 [0.25-0.45],2.0816062297137613e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,17770,611,1.57 [1.39-1.77],1.0537869955513913e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,18201,625,3.17 [2.56-3.92],2.128510536518641e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,17817,612,2.68 [2.20-3.25],2.766595798241169e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,20749,742,1.55 [1.32-1.82],7.374509711524666e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GM2A,Ganglioside GM2 activator,17783,617,2.00 [1.74-2.30],4.4883217876054335e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,17844,612,0.49 [0.39-0.62],1.4124836247954064e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,21111,758,3.00 [2.31-3.91],2.4712513680324597e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20281,729,1.23 [1.14-1.32],1.93476381905076e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,20846,753,0.66 [0.62-0.69],1.1297075626184204e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,21118,762,2.30 [1.85-2.87],1.4046203621142177e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,20749,742,0.61 [0.54-0.69],2.5013935281015032e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,18152,622,1.60 [1.40-1.83],9.529635403882155e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,20372,738,3.74 [2.96-4.72],1.563660613850538e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR15L,Protein GPR15L,18143,620,1.43 [1.26-1.61],8.483768597025709e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,20544,736,2.06 [1.87-2.28],4.6734461975085584e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,18152,622,1.80 [1.62-2.00],4.206686131696623e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,20857,746,4.03 [3.13-5.18],2.3310276456797068e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",20846,753,1.73 [1.57-1.91],2.1781386534437449e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,18181,627,0.16 [0.11-0.24],4.77721006920507e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSR,"Glutathione reductase, mitochondrial",18136,629,0.48 [0.34-0.66],9.40566204399536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,20912,755,1.24 [1.15-1.34],3.134206076002928e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCA2A,Guanylin,20848,750,1.89 [1.59-2.25],3.475851346277869e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,21057,757,1.39 [1.26-1.54],1.2480621617046483e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMB,Granzyme B,20891,749,0.79 [0.70-0.88],4.376024253548397e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,21118,762,1.34 [1.28-1.41],3.0724533517606027e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,21082,762,2.78 [2.55-3.03],5.0542025078531144e-117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,20961,753,3.14 [2.66-3.70],2.079603895032635e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,17844,612,3.13 [2.35-4.17],5.828556583809272e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,21152,759,2.82 [2.39-3.32],7.598746660767536e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,18161,625,1.99 [1.76-2.24],1.7621683242881625e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,18196,621,1.50 [1.29-1.74],1.0455379498317932e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",20831,745,1.61 [1.35-1.93],1.707971375369644e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20891,749,2.76 [2.28-3.34],8.052957707405643e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,17813,609,1.63 [1.41-1.89],6.125706641694736e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,20705,747,0.43 [0.37-0.50],2.9859553554106835e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,20646,740,1.59 [1.38-1.82],3.912533270543755e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,20481,735,0.36 [0.30-0.44],9.211087514658976e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17770,611,1.62 [1.34-1.94],3.363057640903363e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,18166,624,2.15 [1.67-2.78],3.981370677205416e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17696,610,2.66 [2.19-3.22],5.0852662874587227e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,20891,749,0.44 [0.37-0.52],4.6486229006909243e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,18152,622,2.13 [1.78-2.55],1.2997512147602762e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,21118,762,2.65 [2.30-3.07],2.507085290822183e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20821,743,2.96 [2.42-3.62],3.9230525451136076e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,20869,745,7.80 [5.89-10.33],1.2534158315144571e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,20879,742,1.84 [1.48-2.29],3.378386491761774e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM2,Intercellular adhesion molecule 2,21203,763,1.75 [1.42-2.16],2.1650079806277885e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,20891,749,0.59 [0.52-0.67],7.509286893788565e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,20948,755,1.34 [1.16-1.54],5.864748577041628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,20471,728,1.33 [1.17-1.52],1.780356332368066e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDS,Iduronate 2-sulfatase,21152,759,0.13 [0.07-0.24],1.671639068450398e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,21118,762,2.10 [1.80-2.44],2.1207916754279374e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17682,601,2.13 [1.77-2.57],1.0887749347592845e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR1,Interferon gamma receptor 1,21031,754,2.37 [1.78-3.16],3.986582912714415e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,20749,742,1.59 [1.41-1.80],1.2676824204053538e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,20471,728,1.55 [1.36-1.78],2.208670024439177e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,20846,753,3.43 [2.61-4.52],1.1744709544472837e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,20961,753,2.87 [2.15-3.83],1.0118494536699502e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,21169,762,0.85 [0.80-0.90],3.009682484183823e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,21065,749,0.29 [0.25-0.34],1.0618411800592578e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,20688,747,2.84 [2.54-3.18],1.3924314445712323e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP6,Insulin-like growth factor-binding protein 6,20873,744,2.89 [2.46-3.40],3.274851962284102e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,21203,763,3.27 [2.79-3.84],1.2851422629786954e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,20948,755,2.59 [2.18-3.07],8.027203831212302e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,18229,620,2.36 [1.96-2.83],4.3963576811333056e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,20846,753,2.97 [2.58-3.43],4.886935161231486e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,20948,755,3.06 [2.52-3.71],5.7205735245845334e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,18235,622,1.46 [1.33-1.60],4.032330906474204e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,20563,744,1.24 [1.16-1.33],1.2007523887713892e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,21031,754,3.69 [3.01-4.53],3.387322979035584e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,20846,753,1.41 [1.30-1.52],9.6862010455192e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,21152,759,1.62 [1.45-1.82],9.779222132145994e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,20563,744,2.25 [1.91-2.66],1.1734887887981557e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,20891,749,1.84 [1.51-2.23],7.37019558234374e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,20563,744,2.44 [2.02-2.94],1.2837667055863658e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17A,Interleukin-17A,20534,743,1.38 [1.21-1.58],2.259036176990374e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,20563,744,1.65 [1.54-1.78],1.0543280915369e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,20872,749,1.62 [1.42-1.86],8.506894049658687e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,21065,749,3.76 [3.14-4.50],8.217014684098824e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,21152,759,4.78 [3.93-5.81],1.918536725174076e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,20406,739,1.47 [1.36-1.60],8.526316793916826e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,20902,747,3.67 [2.60-5.18],1.5522571393678004e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,21142,760,2.42 [2.10-2.79],9.295656800010772e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,20903,750,1.69 [1.53-1.87],6.8530903412974045e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL22,Interleukin-22,18152,622,1.39 [1.26-1.53],5.389682504204634e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,20782,746,1.93 [1.67-2.23],2.1861706589877864e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,20563,744,1.89 [1.56-2.29],9.693995093049806e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,20891,749,2.51 [2.16-2.91],1.5327505449052789e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,20891,749,1.60 [1.44-1.79],6.439755561795225e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,20846,753,1.23 [1.14-1.33],6.89305334175347e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,20948,755,6.41 [4.44-9.26],4.3784507306707457e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL7R,Interleukin-7 receptor subunit alpha,20961,753,0.68 [0.60-0.78],3.125687785884545e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,18152,622,2.23 [1.96-2.54],5.394743315449942e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,17844,612,2.06 [1.81-2.35],4.017172276956228e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,20961,753,2.24 [1.87-2.69],7.769474253288592e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,18201,625,1.17 [1.11-1.25],7.397434018656226e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL4,Early placenta insulin-like peptide,18152,622,1.49 [1.32-1.68],1.2739524905142167e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,18143,620,1.50 [1.39-1.61],9.862594435794445e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,17696,610,3.15 [2.04-4.86],2.0214478903097726e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,20846,753,1.30 [1.15-1.46],3.157643440687869e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,20891,749,0.29 [0.24-0.35],6.695953737033021e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,17844,612,0.47 [0.38-0.59],1.7784073333646138e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,20961,753,3.18 [2.47-4.11],4.971939128224511e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA6,Integrin alpha-6,20891,749,0.74 [0.64-0.85],3.940315087227493e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,17696,610,1.49 [1.23-1.81],4.692650724925706e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,20563,744,3.18 [2.58-3.91],8.011504938255583e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,21118,762,1.46 [1.28-1.68],4.719672461035269e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,18244,625,3.91 [3.34-4.59],7.619474805575086e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21065,749,1.94 [1.62-2.32],6.140518464199227e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,21111,758,3.59 [2.94-4.38],4.2128065864271104e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,17844,612,1.56 [1.34-1.81],6.547541547853634e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JCHAIN,Immunoglobulin J chain,20563,744,1.31 [1.17-1.46],1.5043689692989422e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JUN,Transcription factor AP-1,20563,744,1.40 [1.24-1.57],1.3934365867310292e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20846,753,1.57 [1.34-1.83],1.432084975386046e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,17770,611,1.36 [1.19-1.55],4.513715597268632e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,21020,749,0.63 [0.50-0.78],3.4473802977292006e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,20471,728,1.34 [1.22-1.47],4.630655438812556e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK11,Kallikrein-11,20838,751,2.36 [2.01-2.77],2.60166717931609e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,21118,762,0.75 [0.65-0.86],4.9769461908475374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,18244,625,1.10 [1.05-1.15],5.118739777445381e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,21118,762,2.14 [1.96-2.34],9.125535117754797e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK6,Kallikrein-6,20988,755,1.75 [1.42-2.16],1.614455029282388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,17393,596,0.56 [0.45-0.70],2.522003503552683e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK8,Kallikrein-8,20252,728,1.46 [1.23-1.73],1.6368113625110483e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLKB1,Plasma kallikrein,17878,617,0.36 [0.27-0.49],3.0337735040535656e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,21152,759,4.93 [4.23-5.75],6.781892274324458e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,21152,759,1.44 [1.25-1.65],6.255661009899371e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,17696,610,1.46 [1.28-1.66],1.9851124993529747e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,18201,625,1.85 [1.58-2.17],1.7067807818619708e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",20846,753,1.73 [1.62-1.85],1.0782593996554459e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",20850,748,1.96 [1.81-2.13],6.849884283942127e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",17634,602,1.63 [1.53-1.73],2.079746687516004e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LACRT,Extracellular glycoprotein lacritin,18117,618,0.64 [0.52-0.79],2.539512586966148e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,20846,753,2.12 [1.84-2.44],3.099130848395308e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20935,749,2.61 [2.28-3.00],8.337988925388696e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20749,742,1.17 [1.09-1.25],5.156607628633334e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,17770,611,3.05 [2.32-4.01],1.3615327928496249e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,17721,613,1.49 [1.23-1.80],5.75508340685919e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,20715,740,3.52 [3.04-4.09],1.5203009700585816e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,21065,749,1.48 [1.32-1.66],2.393333586403532e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,21111,758,1.24 [1.13-1.35],2.528349663504099e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,18196,621,1.75 [1.60-1.92],3.436262454380477e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,20371,728,2.06 [1.78-2.39],2.493192769024457e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCP1,Plastin-2,18244,625,0.58 [0.48-0.69],4.924800983952481e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,20996,754,0.73 [0.64-0.83],2.366989922603505e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEO1,RNA polymerase-associated protein LEO1,18196,621,1.45 [1.20-1.74],8.726858106311893e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,20948,755,0.82 [0.76-0.89],1.2240024572171896e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,18196,621,1.74 [1.53-1.98],8.678528959517894e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,20948,755,1.77 [1.48-2.12],3.2097315111201457e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3,Galectin-3,21004,751,2.06 [1.66-2.54],2.5906611691007047e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,18266,624,2.40 [1.95-2.95],8.900496956549843e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,20935,749,5.14 [4.59-5.76],2.396041653426308e-176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,20931,748,2.49 [2.05-3.01],8.272549337349616e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,21031,754,1.88 [1.57-2.26],1.4690760722568288e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20907,755,1.75 [1.43-2.15],8.18279870316972e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21203,763,1.70 [1.34-2.17],1.3394660088908887e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21117,758,1.74 [1.42-2.12],5.548650479634709e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20563,744,2.09 [1.82-2.40],1.7269604673497827e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,17770,611,1.31 [1.16-1.48],2.010283671055729e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMNB2,Lamin-B2,18201,625,1.82 [1.43-2.31],9.519620143089706e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD1,Leiomodin-1,18196,621,2.29 [1.94-2.69],5.213218362732564e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LONP1,"Lon protease homolog, mitochondrial",17770,611,1.24 [1.13-1.36],5.031088071678898e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,20846,753,1.29 [1.14-1.46],8.17491340337825e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,20948,755,0.42 [0.38-0.48],1.8389211314919602e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,20212,722,1.80 [1.62-2.01],3.2544016762750207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17605,602,1.27 [1.13-1.42],7.333822028038093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21046,760,1.87 [1.55-2.25],4.4941129616234196e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17635,609,2.11 [1.67-2.66],3.8897910734672316e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,20948,755,2.56 [2.17-3.03],1.7795911384356607e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC38,Leucine-rich repeat-containing protein 38,17732,612,1.36 [1.17-1.59],5.5386661047117295e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,20563,744,0.56 [0.47-0.66],2.5509861582993863e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,18196,621,0.40 [0.29-0.55],1.6682484361251504e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA4H,Leukotriene A-4 hydrolase,21118,762,0.74 [0.65-0.83],1.0854549344751305e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,21203,763,1.97 [1.65-2.36],1.760161031755247e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,20481,735,1.54 [1.38-1.71],3.2645574964031863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,20848,746,2.71 [2.23-3.29],6.131494588971968e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,20839,747,1.57 [1.35-1.82],2.9837557399748302e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,20677,749,1.93 [1.56-2.39],1.0203963667966811e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,20749,742,2.13 [1.80-2.52],1.5092230605545213e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,20856,750,1.63 [1.35-1.97],2.703675943303469e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,20481,735,1.44 [1.28-1.63],3.98835391427374e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,18266,624,2.56 [1.74-3.76],1.6443008040706176e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYZL2,Lysozyme-like protein 2,17569,603,1.70 [1.42-2.04],1.1861706815262493e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,20674,737,1.42 [1.28-1.58],5.354012868290927e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,18235,622,2.31 [1.90-2.81],3.4750739017828896e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,18235,622,1.56 [1.36-1.79],1.9978993552353847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC1,MANSC domain-containing protein 1,21030,757,1.92 [1.53-2.41],2.4188314643902107e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAP2,Microtubule-associated protein 2,18201,625,1.37 [1.17-1.60],9.043199265509652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAPK13,Mitogen-activated protein kinase 13,17569,603,1.40 [1.19-1.66],5.344781858215542e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,20714,742,0.38 [0.31-0.47],1.932972421238799e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,21203,763,1.62 [1.47-1.80],9.943818590790603e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCFD2,Multiple coagulation factor deficiency protein 2,20840,751,1.48 [1.27-1.72],5.84080795734816e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,20971,755,1.86 [1.68-2.07],2.7762075397144057e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17770,611,1.20 [1.10-1.31],3.5240192741989105e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,20935,749,0.61 [0.51-0.73],6.59393897361858e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,17844,612,0.12 [0.09-0.16],1.553788031973126e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,18143,620,1.37 [1.24-1.52],2.3778292293820207e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1B,Meprin A subunit beta,20948,755,0.84 [0.80-0.89],1.138179368028526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,20935,749,0.59 [0.47-0.75],1.134590983141728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,21152,759,1.97 [1.54-2.52],7.638742195039246e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,20993,756,0.28 [0.20-0.39],2.7039553229183025e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,17844,612,4.70 [3.72-5.93],1.4588141988343874e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP5,Microfibrillar-associated protein 5,21203,763,1.49 [1.28-1.75],6.895221436491635e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,20961,753,2.95 [2.54-3.42],1.2587571573984683e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,20891,749,1.16 [1.10-1.23],6.381232419327194e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,20563,744,1.54 [1.36-1.75],2.470475709215183e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,20891,749,1.29 [1.20-1.40],8.470303226411503e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,20846,753,1.52 [1.41-1.64],8.211190366043403e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,20159,716,1.28 [1.18-1.39],3.0416300307516072e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,20881,749,2.02 [1.83-2.24],2.8600832406486177e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,20942,755,2.37 [2.13-2.65],3.2547106435773314e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP3,Stromelysin-1,20961,753,1.64 [1.47-1.82],5.0793801958645713e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,20512,735,2.78 [2.41-3.20],1.8165143625236512e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,21071,757,1.30 [1.19-1.43],6.2603362809431334e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,20920,753,1.34 [1.20-1.50],2.221504682662952e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MPRIP,Myosin phosphatase Rho-interacting protein,18113,619,0.64 [0.53-0.78],9.78418038376059e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,18244,629,3.77 [2.95-4.83],6.127395778644213e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSMB,Beta-microseminoprotein,20902,751,1.36 [1.25-1.49],9.473223792604324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,21111,758,2.66 [2.31-3.07],8.987527644717024e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTDH,Protein LYRIC,17696,610,1.22 [1.12-1.33],4.625843206372486e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,17900,617,1.40 [1.23-1.59],2.9234630799762544e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,20471,728,5.37 [4.71-6.12],1.3523132945736411e-139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,20563,744,1.63 [1.51-1.76],8.75218600414689e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,17844,612,0.18 [0.14-0.23],1.0527587615507386e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",18235,622,1.45 [1.31-1.59],4.256718811600735e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",17770,611,1.28 [1.19-1.38],9.383847658545622e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17605,602,1.46 [1.26-1.70],1.0261745073431417e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL3,Myosin light chain 3,17770,611,1.37 [1.24-1.52],1.933902631839995e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYL4,Myosin light chain 4,17770,611,1.34 [1.18-1.52],8.74884251878864e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17732,612,1.57 [1.40-1.77],2.5979109084053688e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,20961,753,0.72 [0.62-0.84],1.8601966888294286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MZB1,Marginal zone B- and B1-cell-specific protein,21002,753,1.59 [1.41-1.79],2.0838124958643487e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGK,N-acetyl-D-glucosamine kinase,17741,611,0.65 [0.56-0.76],4.6588514831280826e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,17844,612,2.63 [1.82-3.78],2.1557489810223597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,21030,757,6.00 [4.86-7.42],1.1483059928037273e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAM2,Neural cell adhesion molecule 2,20961,753,0.57 [0.44-0.73],1.2740387964093765e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,21111,758,0.24 [0.21-0.29],2.8928974743226992e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,20857,747,2.65 [2.25-3.12],3.3083341122651327e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,18143,620,4.37 [3.61-5.29],3.3715240415541885e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,21118,762,5.11 [4.14-6.32],1.6869007433102432e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,17677,610,1.57 [1.25-1.97],9.066035753536384e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEB,Nebulin,17605,602,1.49 [1.26-1.76],3.20472003310676e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,20907,755,5.09 [4.23-6.12],5.282896417654232e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,21030,757,3.07 [2.63-3.58],1.1794608998794356e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,20409,727,2.28 [2.01-2.58],2.7599036186881127e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,21030,757,0.34 [0.29-0.40],1.9467037724720131e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",20563,744,1.38 [1.24-1.53],1.3083318148735668e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGFR,Tumor necrosis factor receptor superfamily member 16,18235,622,1.82 [1.47-2.26],3.430409981875439e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,18201,625,2.41 [1.85-3.14],6.232253508942574e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,17393,596,3.76 [2.89-4.88],3.2432711032225775e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,20963,750,0.43 [0.32-0.59],6.844208756256663e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,20961,753,2.38 [1.79-3.18],3.024574303173591e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",20471,728,1.71 [1.54-1.91],3.629925011736892e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",20471,728,1.51 [1.37-1.67],5.220452313692837e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,17930,620,4.14 [3.45-4.98],8.041039766762471e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,20948,755,2.58 [2.20-3.03],4.597473597189484e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPHS1,Nephrin,17696,610,0.57 [0.44-0.74],2.165147225245666e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,18235,622,1.41 [1.20-1.66],2.591342902703272e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPB,Natriuretic peptides B,20544,736,1.20 [1.14-1.26],1.403894371278918e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPC,C-type natriuretic peptide,20891,749,1.49 [1.34-1.65],1.683044476189221e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX2,Neuronal pentraxin-2,18244,625,2.15 [1.75-2.64],4.0469068140046473e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,21118,762,2.57 [2.29-2.89],2.572574301521228e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,20948,755,4.36 [3.55-5.36],5.770173731622288e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,21093,751,6.94 [5.48-8.79],4.5408462610888114e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,18201,625,2.17 [1.81-2.59],1.615667718898867e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,20891,749,1.63 [1.38-1.93],1.3454006779684153e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,21111,758,0.22 [0.16-0.30],3.6585534718160335e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,20948,755,1.36 [1.29-1.43],1.4473721925246014e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,21074,760,1.83 [1.54-2.18],1.589751463072536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,20683,740,1.20 [1.10-1.32],7.415331479759409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,18196,621,2.60 [2.25-3.00],1.2088313733021975e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,20961,753,2.18 [1.90-2.50],4.3774715862315615e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,17180,593,1.38 [1.28-1.49],4.289469795135647e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,21031,754,0.39 [0.34-0.45],2.0915416068211376e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,20846,753,0.67 [0.60-0.74],3.4327904596397373e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,20846,753,0.70 [0.60-0.82],1.067873810602018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ORM1,Alpha-1-acid glycoprotein 1,18197,622,0.42 [0.28-0.63],3.586072654023764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,20963,750,1.93 [1.59-2.35],3.189409772164045e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,20800,745,1.31 [1.19-1.44],3.4797784944703624e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,21111,758,1.19 [1.14-1.25],2.798913292972487e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,20860,749,1.54 [1.29-1.83],1.168235372358757e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PADI2,Protein-arginine deiminase type-2,20563,744,1.24 [1.12-1.38],3.781772047350584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,20544,736,1.58 [1.41-1.76],3.538993941957141e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM,Paralemmin-1,18040,617,1.74 [1.41-2.16],3.391133203071036e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,18201,625,3.19 [2.69-3.77],3.689076406179905e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,18143,620,1.99 [1.61-2.46],1.7934176140199587e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,17817,612,1.63 [1.40-1.90],7.13185792547322e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,21087,757,2.35 [1.82-3.04],6.336371732700725e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,20948,755,2.65 [2.25-3.12],9.194462876029408e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH7,Protocadherin-7,18143,620,1.63 [1.38-1.91],5.085773794714381e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDHB15,Protocadherin beta-15,18152,622,1.56 [1.30-1.86],1.0011976465893257e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,21203,763,2.06 [1.75-2.43],4.6283181387602295e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,21079,760,1.73 [1.53-1.97],3.902219986139436e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,20846,753,3.20 [2.63-3.90],6.12259117292912e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,20948,755,3.07 [2.46-3.82],1.7361573285163362e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDIA3,Protein disulfide-isomerase A3,17844,612,1.94 [1.46-2.57],4.578804387023741e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17696,610,2.42 [2.10-2.79],7.379628942591144e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEAR1,Platelet endothelial aggregation receptor 1,21203,763,1.85 [1.37-2.49],5.527071560305178e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PECAM1,Platelet endothelial cell adhesion molecule,20961,753,1.55 [1.25-1.92],5.939905284032694e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PENK,Proenkephalin-A,17844,612,1.76 [1.43-2.16],5.776260113349642e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,18244,629,0.25 [0.18-0.33],3.4051716075899033e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,18244,629,1.73 [1.57-1.90],3.575394386280188e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,21152,759,4.85 [3.97-5.93],1.0876885942567623e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGLYRP1,Peptidoglycan recognition protein 1,21117,758,1.45 [1.26-1.67],3.147840263204442e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHLDB1,Pleckstrin homology-like domain family B member 1,18143,620,1.47 [1.27-1.70],2.0501767847558617e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,20749,742,2.62 [2.09-3.27],2.7061672321290788e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,20689,746,1.70 [1.54-1.88],1.506292666961711e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,20681,742,5.82 [4.91-6.90],6.004277673318557e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,20961,753,5.05 [4.22-6.03],6.174954287573007e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,20961,753,2.84 [2.43-3.34],7.566368022023364e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,20948,755,1.94 [1.71-2.21],2.9904218788161795e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,18235,622,4.52 [3.36-6.06],9.658157863184509e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G10,Group 10 secretory phospholipase A2,20749,742,1.70 [1.51-1.91],3.2712963220157337e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,21030,757,3.72 [2.95-4.70],2.722549402054477e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,21174,763,0.75 [0.65-0.87],8.190405031071746e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,20961,753,0.14 [0.12-0.17],1.1630665053688474e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,20801,744,4.21 [3.41-5.19],6.365498106710177e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",18201,625,0.75 [0.66-0.85],1.285177837015061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,20948,755,1.75 [1.51-2.03],1.3576412703621148e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,21144,759,0.53 [0.45-0.63],1.0042869785854869e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,18201,625,1.92 [1.52-2.42],3.9060898055371545e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIP,Pancreatic triacylglycerol lipase,18244,629,1.35 [1.20-1.51],3.7726861464703353e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,18201,625,1.34 [1.22-1.47],1.4053992057411028e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,17696,610,2.00 [1.75-2.29],3.4496099332927475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20846,753,1.54 [1.31-1.79],6.316040679055282e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,18244,629,0.20 [0.16-0.26],6.73478969444389e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,21031,754,0.30 [0.24-0.36],1.2566888241243373e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPL,Periplakin,17696,610,1.64 [1.33-2.03],4.27501670485957e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18196,621,1.83 [1.56-2.14],5.103622147180474e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,20941,748,1.45 [1.36-1.54],1.066405748849039e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,21089,760,5.40 [4.42-6.59],1.6256516874187107e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,20563,744,1.96 [1.61-2.38],2.148160784463069e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRELP,Prolargin,20935,749,1.82 [1.39-2.38],1.4212120922012086e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG2,Bone marrow proteoglycan,18244,625,1.64 [1.42-1.89],1.0040839195214329e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,20563,744,1.30 [1.16-1.47],1.5517902621245295e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRND,Prion-like protein doppel,18201,625,1.41 [1.23-1.62],1.2988846327405562e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROC,Vitamin K-dependent protein C,21020,749,0.49 [0.38-0.63],2.4361736970530694e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROK1,Prokineticin-1,20891,749,1.45 [1.33-1.58],2.853768589639468e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,18266,624,0.47 [0.35-0.64],7.036993233985297e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS2,Trypsin-2,21065,749,1.39 [1.25-1.54],2.5972969433718435e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,17696,610,1.80 [1.54-2.12],6.141828375798699e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,20888,752,1.50 [1.27-1.77],1.276101941550046e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,20862,750,5.23 [4.52-6.06],6.205928618162245e-108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,21118,762,2.16 [1.66-2.81],1.0188750359737134e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRUNE2,Protein prune homolog 2,17900,617,1.59 [1.26-2.01],8.410979443604306e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,18068,624,3.73 [2.98-4.66],5.892699827504314e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,20749,742,1.30 [1.21-1.39],4.511533520952957e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSPN,Persephin,20891,749,1.29 [1.22-1.35],1.7504150889351418e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,20812,742,4.06 [3.46-4.77],6.7479471586435705e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGES2,Prostaglandin E synthase 2,17565,603,1.39 [1.20-1.61],1.1328392634030944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,18235,622,1.50 [1.37-1.64],1.2344862816489545e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20891,749,1.50 [1.31-1.71],2.416117121423384e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,20471,728,2.60 [2.18-3.09],8.322200709662332e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,17696,610,1.48 [1.30-1.68],2.3837101480755278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,18235,622,2.09 [1.59-2.73],9.47916407076179e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,18244,625,2.01 [1.47-2.75],1.1753498261550518e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,18143,620,1.78 [1.52-2.08],3.8463378337602165e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18143,620,2.46 [1.83-3.32],2.869491314702057e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,20866,749,1.99 [1.52-2.61],6.698356596889597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,20686,740,1.92 [1.59-2.31],6.186248441990348e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,20372,725,1.47 [1.32-1.64],9.455669983714788e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,20891,749,1.56 [1.33-1.82],4.11537063748837e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,21111,758,2.31 [1.96-2.72],2.2270615080885282e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,17605,602,2.05 [1.91-2.21],6.682438262366529e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PZP,Pregnancy zone protein,18266,624,0.62 [0.54-0.70],2.394868527952461e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,20997,757,3.16 [2.53-3.95],6.227707888378678e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,17916,613,1.71 [1.51-1.93],4.135439354850684e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,20891,749,0.37 [0.32-0.43],4.2208712990570025e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,20481,735,1.74 [1.50-2.02],2.1864401363735813e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,21093,751,1.63 [1.44-1.85],4.043902343969692e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,18196,621,2.70 [2.33-3.12],4.117004579998091e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,20846,753,1.64 [1.51-1.79],1.5697792473888631e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,20846,753,2.00 [1.80-2.22],3.936068928272012e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,18143,620,1.43 [1.28-1.60],8.376519409248596e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,20833,741,3.44 [3.11-3.82],2.9481057365399237e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,21203,763,2.39 [2.18-2.61],4.8878822004748616e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,21203,763,1.80 [1.65-1.97],2.084943198914378e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,20963,750,5.37 [4.76-6.06],9.99641329573062e-166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,20961,753,3.05 [2.55-3.65],1.409883686385984e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,20948,755,2.34 [2.20-2.49],1.8105238627665027e-157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20846,753,2.05 [1.73-2.43],9.731539388286615e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,20904,754,1.54 [1.33-1.78],4.8042590554798336e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMA,Repulsive guidance molecule A,21111,758,2.09 [1.70-2.57],2.1118842244143635e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMB,RGM domain family member B,21111,758,2.11 [1.70-2.62],1.5910744639153806e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17844,612,1.90 [1.65-2.19],1.109262310780094e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RLN2,Prorelaxin H2,17809,610,1.35 [1.17-1.56],2.998891471836624e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,18244,629,4.07 [3.23-5.13],9.450792874779947e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE10,Inactive ribonuclease-like protein 10,17770,611,1.65 [1.44-1.89],8.987346214749473e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,17624,609,3.37 [2.71-4.20],7.620985109830609e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,18111,625,2.79 [2.37-3.29],3.73270209156218e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,21114,761,5.64 [4.57-6.96],2.930363834595844e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,17770,611,3.77 [3.02-4.71],1.362381410379597e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,20963,750,1.94 [1.52-2.47],7.880104149423588e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20948,755,1.57 [1.28-1.91],1.352456998370274e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,21118,762,1.88 [1.52-2.31],3.362630691033327e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTBDN,Retbindin,20846,753,1.50 [1.22-1.84],9.54626527888192e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,21118,762,6.83 [5.71-8.18],5.666707827352816e-97
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,18196,621,0.36 [0.30-0.43],4.413580036884288e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A16,Protein S100-A16,20441,727,0.70 [0.62-0.79],1.53392635675533e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100G,Protein S100-G,18196,621,0.69 [0.58-0.83],6.888441124846207e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,20544,736,1.51 [1.37-1.67],4.309091313169609e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,17900,617,1.27 [1.14-1.41],1.405030525780321e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCAMP3,Secretory carrier-associated membrane protein 3,20846,753,1.21 [1.12-1.31],2.85478336271506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,21111,758,4.10 [3.37-4.98],9.594386618626177e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,20358,724,3.31 [2.82-3.88],4.3416280707609196e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,21203,763,1.57 [1.34-1.83],1.4489584341419196e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,21111,758,2.94 [2.38-3.62],5.90999658635115e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,21002,758,6.04 [5.02-7.25],4.5252593454361045e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGB1A1,Uteroglobin,20949,753,1.30 [1.15-1.47],2.27482551231474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,20563,744,2.88 [2.52-3.30],6.326716739947212e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,21046,760,1.47 [1.29-1.69],1.2182680079951162e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCN4B,Sodium channel subunit beta-4,17770,611,1.70 [1.42-2.02],3.181705427112407e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,17699,610,1.73 [1.47-2.02],1.6466102327111647e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCRG1,Scrapie-responsive protein 1,18235,622,1.87 [1.46-2.39],7.738053203483947e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,20948,755,1.89 [1.64-2.19],2.0226876157920347e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC4,Syndecan-4,20948,755,0.61 [0.53-0.69],7.560748566257898e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,17770,611,2.40 [2.05-2.82],3.433277244426872e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,21203,763,2.30 [2.01-2.63],2.22431743977634e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELL,L-selectin,18266,624,0.36 [0.26-0.50],7.043738880473168e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,20891,749,2.20 [1.71-2.84],9.259368103758275e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,20948,755,2.14 [1.68-2.73],7.938007463607616e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3G,Semaphorin-3G,17844,612,1.55 [1.32-1.83],1.4060432395703268e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,21142,760,2.98 [2.47-3.61],1.0939096324731939e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN8,Septin-8,18173,624,2.61 [2.15-3.17],1.7852106623441421e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA1,Alpha-1-antitrypsin,17901,618,6.23 [2.70-14.37],1.7934209966260637e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,20743,753,1.27 [1.16-1.39],2.0759493667531185e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINB8,Serpin B8,21152,759,1.27 [1.15-1.40],1.482309709137969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,17980,617,5.38 [4.07-7.12],4.1952247255759273e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPING1,Plasma protease C1 inhibitor,18236,624,0.37 [0.24-0.56],2.604260330857628e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,17817,612,0.35 [0.26-0.47],1.9195317723137776e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,20678,741,0.52 [0.41-0.66],4.786539738239376e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L,Seizure 6-like protein,21030,757,1.62 [1.29-2.03],3.289843413709184e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SF3B4,Splicing factor 3B subunit 4,20846,753,0.82 [0.75-0.90],5.560184971594463e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,20685,742,1.33 [1.15-1.53],8.82268721351288e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,20948,755,1.22 [1.11-1.34],5.972906537328791e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,17905,617,1.50 [1.31-1.71],1.805406682373997e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,18244,629,0.50 [0.43-0.58],2.549229181652279e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,18244,625,4.16 [3.39-5.11],2.1396630581290477e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,20995,757,1.58 [1.37-1.82],2.687506959202774e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,21031,754,2.45 [2.12-2.84],1.875636890930787e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,20891,749,2.80 [2.37-3.31],9.341958150538742e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,20961,753,1.28 [1.20-1.37],2.6441313339909907e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,21118,762,2.54 [2.13-3.03],2.0146974885316363e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,20948,755,3.18 [2.53-4.00],5.455168150668932e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,17770,611,1.70 [1.43-2.01],1.6526079783819303e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,21012,755,1.30 [1.15-1.48],3.211893487615618e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,20909,749,2.26 [1.98-2.59],5.2912304286230836e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,20563,744,1.91 [1.70-2.15],4.7756408950477555e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,20563,744,1.82 [1.63-2.04],1.4263465061557757e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,20481,735,1.49 [1.25-1.76],6.7448587373572126e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,20891,749,1.52 [1.36-1.69],1.7008273727662032e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,20481,735,1.74 [1.53-1.98],2.5598672311400214e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,20471,728,1.30 [1.18-1.44],2.641318522661106e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC39A5,Zinc transporter ZIP5,20891,749,1.26 [1.12-1.41],8.102468995697622e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC51B,Organic solute transporter subunit beta,17605,602,0.74 [0.66-0.84],4.505196971366009e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18143,620,1.44 [1.28-1.63],1.2977977491913291e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,21118,762,1.65 [1.40-1.95],2.123957158957526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK6,SLIT and NTRK-like protein 6,20544,736,2.74 [2.30-3.26],8.011021480555846e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,18143,620,1.39 [1.27-1.52],2.336235797879552e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,18113,622,1.45 [1.21-1.72],3.605636208714059e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD5,Mothers against decapentaplegic homolog 5,20846,753,0.40 [0.29-0.55],3.3178831102664104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,21118,762,2.52 [2.09-3.05],1.0138639004525024e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,21031,754,2.28 [1.97-2.65],1.1766612007932055e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,21004,756,1.94 [1.71-2.21],2.083867940597252e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMTN,Smoothelin,18175,624,1.22 [1.12-1.32],2.3171189824108523e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAPIN,SNARE-associated protein Snapin,18196,621,0.74 [0.64-0.86],7.16335619952688e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,20749,742,1.49 [1.35-1.64],3.019105864197601e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17770,611,1.77 [1.45-2.16],2.1201371066877425e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',18201,625,1.35 [1.18-1.53],9.342186489363707e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORBS1,Sorbin and SH3 domain-containing protein 1,18196,621,1.41 [1.22-1.64],6.104152947560547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,20481,735,2.71 [2.29-3.20],7.892957815253399e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SOX9,Transcription factor SOX-9,17732,612,1.84 [1.37-2.47],5.223413174371545e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,18196,621,1.90 [1.54-2.33],1.0428539831223766e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPESP1,Sperm equatorial segment protein 1,18235,622,1.69 [1.36-2.10],2.371606177470809e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,20961,753,4.84 [4.30-5.46],5.32035130741351e-147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK2,Serine protease inhibitor Kazal-type 2,17844,612,1.57 [1.31-1.90],1.849659317075016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,20891,749,2.93 [2.68-3.20],1.4542771992098532e-125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,20897,751,2.69 [2.17-3.32],7.162896589577183e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,21031,754,2.59 [2.19-3.06],7.903465677716178e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT3,Kunitz-type protease inhibitor 3,18143,620,1.12 [1.09-1.16],4.0873716221420224e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,20749,742,0.23 [0.18-0.30],1.7770462093864922e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,20963,750,3.39 [2.85-4.03],9.962635619509208e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,20845,752,4.75 [4.01-5.63],3.340235247594827e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPX,Sushi repeat-containing protein SRPX,18235,622,1.57 [1.26-1.94],4.09116578699127e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,21065,749,1.54 [1.31-1.81],1.4508500369625956e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21203,763,1.78 [1.45-2.18],4.28683637013963e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,18244,625,2.03 [1.53-2.70],8.281020119494992e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,21111,758,1.77 [1.55-2.02],4.1991778772756e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC2,Stanniocalcin-2,20934,750,1.95 [1.50-2.55],7.484439121938402e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX4,Syntaxin-4,20846,753,1.31 [1.19-1.44],7.27590660416699e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX7,Syntaxin-7,17696,610,1.56 [1.32-1.85],1.5033027926756516e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STX8,Syntaxin-8,20891,749,1.31 [1.14-1.50],9.65885989949238e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,20891,749,1.52 [1.38-1.67],5.011496861286855e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",18196,621,1.64 [1.47-1.83],4.608505474605069e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,20961,753,1.62 [1.30-2.01],1.3420408532186982e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD4,Sushi domain-containing protein 4,18152,622,1.50 [1.28-1.76],5.745440697754111e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACSTD2,Tumor-associated calcium signal transducer 2,18512,678,1.80 [1.44-2.24],1.7060631719176738e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAFA5,Chemokine-like protein TAFA-5,20846,753,2.41 [2.06-2.81],7.485572442724125e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TALDO1,Transaldolase,18164,625,1.44 [1.21-1.72],4.598436053194627e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAX1BP1,Tax1-binding protein 1,18201,625,1.32 [1.17-1.48],7.131501072594833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,21178,761,2.84 [2.38-3.39],6.575614633336707e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,18235,622,1.86 [1.53-2.26],5.98899878852195e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,21030,757,3.12 [2.31-4.21],1.17582093925016e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEX101,Testis-expressed protein 101,17732,612,1.52 [1.37-1.68],1.301496116595926e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,18266,624,5.41 [3.76-7.78],8.646293270416521e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,20850,749,1.80 [1.68-1.93],8.377198317573683e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,20992,751,2.56 [2.31-2.83],1.854591456307485e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,20954,745,3.00 [2.69-3.35],4.152411974347509e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI,Tissue factor pathway inhibitor,20921,745,0.43 [0.34-0.54],7.934343568178042e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,21054,749,1.90 [1.61-2.24],1.2678448785433711e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,20891,749,2.24 [1.98-2.53],2.4908136749263955e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,21121,757,1.86 [1.58-2.19],7.88443465252643e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR1,TGF-beta receptor type-1,17696,610,2.56 [1.89-3.48],1.862678398195991e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,21030,757,3.03 [2.60-3.52],6.496858795146883e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGOLN2,Trans-Golgi network integral membrane protein 2,18244,629,2.49 [1.90-3.25],2.7664501154721428e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,20948,755,2.08 [1.69-2.55],3.833468858513231e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,20961,753,2.92 [2.54-3.34],7.417560118563776e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,21111,758,2.31 [1.88-2.83],9.56546747537139e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17900,617,1.78 [1.49-2.13],2.8969015921186795e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,21065,749,0.72 [0.62-0.84],1.6969790768667245e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,20759,739,4.14 [3.39-5.06],3.453959226023418e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,20961,753,0.69 [0.58-0.82],1.2231124628076788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,17696,610,1.87 [1.42-2.46],9.095176666289428e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,21152,759,1.40 [1.24-1.57],3.7938345021362296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,20846,753,1.67 [1.55-1.80],3.95611589875221e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMSB10,Thymosin beta-10,20961,753,1.23 [1.12-1.35],1.433781446086971e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,20517,735,1.80 [1.59-2.04],1.2794664761178641e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20749,742,4.03 [3.37-4.83],6.905185256566425e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20749,742,2.06 [1.85-2.29],2.4147056112090587e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21152,759,4.16 [3.63-4.78],1.825330164151059e-91
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20935,749,3.14 [2.55-3.87],6.885825595932323e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21030,757,4.36 [3.73-5.09],2.072088535473085e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20963,750,1.89 [1.63-2.18],5.224726810310762e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,20963,750,4.67 [3.90-5.60],4.66471820663257e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17844,612,1.63 [1.36-1.95],1.0613152355938059e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21118,762,2.62 [2.24-3.07],3.702438729354716e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,20961,753,5.14 [4.34-6.08],2.7387112696577927e-81
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20961,753,2.51 [2.19-2.87],2.449784114329973e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21111,758,1.97 [1.59-2.45],9.309131314923374e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21121,757,2.90 [2.52-3.33],1.2954210584345028e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20749,742,1.73 [1.57-1.91],1.773464246607411e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21111,758,1.42 [1.25-1.63],1.9762977705643613e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20749,742,2.03 [1.81-2.29],3.556829128777102e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21152,759,0.18 [0.14-0.23],8.292607493571003e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,20891,749,0.64 [0.57-0.72],1.2446443967196472e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,21152,759,0.19 [0.15-0.24],1.7930098225717048e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,21031,754,3.89 [3.09-4.90],5.516335903895024e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21175,762,1.53 [1.24-1.88],6.681392089298913e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,18244,625,1.98 [1.63-2.40],5.407883063644381e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,18244,625,1.63 [1.36-1.96],1.257076859804867e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNNI3,"Troponin I, cardiac muscle",20544,736,1.24 [1.14-1.35],1.665620910034411e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,20961,753,0.31 [0.24-0.40],1.2965106697000237e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,18235,622,1.26 [1.14-1.39],4.474445197833964e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TOP1,DNA topoisomerase 1,18143,620,1.19 [1.11-1.27],8.422783817478434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,18235,622,0.34 [0.25-0.46],1.8640770692913368e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,20790,746,1.84 [1.63-2.09],8.336456154254339e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPSAB1,Tryptase alpha/beta-1,21120,759,1.40 [1.23-1.60],5.099379067676312e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,18244,625,1.70 [1.51-1.91],4.3033733958417174e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,20935,749,1.39 [1.24-1.57],6.63825934364739e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TSPAN1,Tetraspanin-1,20544,736,1.21 [1.13-1.31],2.821680848545066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TTN,Titin,17605,602,1.25 [1.12-1.40],5.799795890768219e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNDC5,Thioredoxin domain-containing protein 5,21111,758,1.34 [1.22-1.48],2.671090594446427e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,20749,742,3.16 [2.74-3.65],1.6135293762001248e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,21147,757,0.36 [0.32-0.40],1.6868818323235953e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,18235,622,1.48 [1.37-1.61],1.6901300060933857e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,18201,625,1.64 [1.40-1.93],1.5795984666519342e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UXS1,UDP-glucuronic acid decarboxylase 1,20481,735,1.34 [1.20-1.51],4.244193682809753e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAMP5,Vesicle-associated membrane protein 5,20544,736,1.28 [1.15-1.42],5.587781655441209e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASN,Vasorin,20641,735,1.85 [1.45-2.36],9.662992166535603e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,20846,753,0.22 [0.15-0.31],3.3012453969361055e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,21020,749,3.87 [3.12-4.81],2.257967182794049e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,21086,756,1.49 [1.33-1.66],1.441506440434227e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFD,Vascular endothelial growth factor D,21119,758,1.74 [1.45-2.08],1.7204201513998332e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,20846,753,1.53 [1.37-1.70],2.7345100795862696e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,18244,629,1.47 [1.31-1.65],1.4942109548950135e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17605,602,1.56 [1.26-1.93],4.492718771068385e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,18152,622,2.62 [2.39-2.88],7.018591226399098e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,20934,750,3.39 [2.97-3.88],1.4177194356639876e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,20912,755,1.23 [1.11-1.37],7.89529294227912e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,20544,736,1.35 [1.23-1.49],1.078353424980062e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,20481,735,1.78 [1.47-2.16],6.395031070989075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,20680,740,1.98 [1.69-2.33],4.2094552069974926e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC1,WAP four-disulfide core domain protein 1,17777,608,1.37 [1.23-1.53],2.7724073028922093e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC12,WAP four-disulfide core domain protein 12,21088,761,1.35 [1.23-1.47],1.4670659820806138e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,19913,719,2.72 [2.41-3.07],1.432653735817386e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",20678,741,0.64 [0.54-0.75],3.420690195113752e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,21118,762,0.24 [0.19-0.29],5.23545045469647e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WNT9A,Protein Wnt-9a,20563,744,2.81 [2.29-3.45],4.0984301447928984e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,21118,762,1.53 [1.38-1.69],7.1124827907319e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,21030,757,0.67 [0.63-0.72],5.5386992121952295e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,18201,625,3.22 [2.58-4.02],3.228531059944239e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,20544,736,1.49 [1.32-1.69],4.753970098153726e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,18143,620,1.41 [1.27-1.57],1.6542002380383528e-10
